Neuromedin S vs Relaxin-3 — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
Neuromedin S (NMS) is a 36-amino acid amidated neuropeptide discovered in 2005 that shares a C-terminal amino acid sequence with neuromedin U (NMU) and activates the same NMUR1 and NMUR2 receptors. However, NMS has a markedly different expression pattern: while NMU is broadly exp...
Calculate Neuromedin S dose →Relaxin-3 (also called INSL7) is the most ancient member of the insulin/relaxin superfamily and is expressed predominantly in the nucleus incertus (NI) of the brainstem, a structure implicated in stress, arousal, and hippocampal theta rhythm generation. Unlike relaxin-1 and relax...
Calculate Relaxin-3 dose →| Parameter | Neuromedin S | Relaxin-3 |
|---|---|---|
| Category | Neuropeptide | Neuropeptide |
| Research | Research | Preclinical Research |
| Half-Life | Short (minutes, estimated) | ~30-60 minutes (estimated) |
| Typical Dose | 1-10 nmol (central, animal) | 100-500 pmol ICV; 1-3 nmol/kg SC |
| Frequency | Variable | Single or twice daily (preclinical) |
| Route | Intracerebroventricular, Subcutaneous | ICV, SC (preclinical) |
| FDA Status | Not approved | Research compound |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.